Figure 1.

Kaplan-Meier Survival by different CHADS2 risk status (High Risk, Intermediate risk and low risk). In the unadjusted Kaplan-Meier analysis, patients with low and intermediate risk have diminished all-cause survival at 48 months compared with those at high risk (93.0% vs 90.1% vs 78.5%, respectively).